Coca-Cola Europacific Partners (CCEP) · Deep analysis

Report previewCCEP.USReport date Last updated
← Back to reports
Report contents

At a glance

  • Business model: CCEP makes, packages and distributes drinks under brands owned mostly by The Coca-Cola Company, selling to retailers and foodservice outlets in 31 countries under exclusive territorial rights. Route density and habitual demand keep volume steady, but concentrate pricing and shelf prices sit largely with TCCC and consolidated grocers.
  • Financial quality: Operating cash flow covered net income 1.5 to 2.2 times in each of the last five fiscal years, and free cash flow was positive in every one of them. It has been roughly flat near €2.2 billion for three years, though, and leverage is high: liabilities are 71% to 75% of assets and goodwill is 58% of equity.
01

Business model

Business model: a bottler's scale with shared brand power

Coca-Cola Europacific Partners plc (CCEP) is a licensed bottler and distributor, not the owner of the Coca-Cola brand. It makes, packages and delivers finished beverages under brands owned mostly by The Coca-Cola Company (TCCC) and other franchisors, then sells them to grocery retailers, convenience stores, restaurants, bars and other outlets across 31 countries. The direct payers are those trade customers, not the roughly 600 million consumers the February 2026 investor deck cites. The deck reports 4 billion unit cases (a standard beverage volume measure) of volume, €21 billion of revenue, €3.7 billion of EBITDA, 41,000 employees and 90 sites. The business is a manufacturer-distributor with exclusive territorial rights. The European core is mature, while the Asia-Pacific footprint added through Coca-Cola Amatil in 2021 and the 2024 Philippines joint acquisition is still in an expansion phase.

Revenue is essentially the sale of finished drinks. The profit pool is concentrated in sparkling soft drinks, especially Coca-Cola trademark beverages, because concentrate costs are low relative to consumer price and the brand carries pricing power. Still drinks, water and energy are smaller and more competitive. CCEP does not break out product-level revenue or gross margin in the February 2026 deck, so the exact share is not public. The missing mix matters: a rising share of lower-margin water or private-label-style products would dilute group profitability even if volume grows. The company also does not disclose country-level profit, which makes it harder to judge whether the Asia-Pacific additions earn returns similar to the European core.

The value chain has three steps: TCCC owns most brands and sells concentrate; CCEP converts concentrate into finished drinks and distributes them; retailers and foodservice outlets control final access to consumers. CCEP's bargaining power is strongest against fragmented small outlets, where route density and cold-drink availability matter, and weakest against TCCC on concentrate pricing and against large grocery chains on shelf price and promotions. The company's 2024 Annual Report on Form 20-F, filed March 21, 2025, lists "changes in relationships with large customers" and "our relationship with TCCC and other franchisors" among risk factors. That is the structural constraint: CCEP can improve execution and cost per case, but it cannot unilaterally set the brand's consumer price or the concentrate price.

Growth now comes from three places: per-capita consumption in emerging markets, revenue per case through premiumization and smaller packs, and acquisitions. The 2021 Amatil deal and the 2024 Philippines deal added volume and geographies, but they also added currency, regulatory and integration risk. Returns depend on whether CCEP can lift distribution and cooler placement in these markets without permanently lower margins. So far the evidence only shows scale: the February 2026 deck shows €21 billion of revenue and €3.7 billion of EBITDA, but not segment-level returns by country or acquisition. If Asia-Pacific revenue per case lags Europe as volume grows, the expansion may be lower-margin and dilute group returns.

End-market demand is defensive but not immune. Sparkling soft drinks are affordable treats with habitual purchase, which supports volume in weak economies. However, sugar taxes, packaging regulation and health concerns can shift demand and raise costs. The February 2026 deck lists waste and pollution, health perceptions, recycling matters, water scarcity and climate change among risk factors. These are slow-moving, but they affect the profit pool if regulation raises the cost per unit or pushes consumers toward lower-margin alternatives. The main judgment is that CCEP is a high-quality distribution franchise with mid-single-digit revenue growth potential but limited pricing power because brand and retail power sit outside the company.

What would overturn that judgment: sustained revenue per case growth ahead of input costs without volume loss, or a renegotiation of concentrate terms that shifts profit to CCEP, would improve the bargaining-power conclusion. Conversely, if large retailers or TCCC captured a bigger share of the profit pool, the franchise would look more fragile. The evidence does not yet establish that CCEP can consistently outpace input-cost inflation through price and mix alone.

Questions worth following

  • Can CCEP lift revenue per unit case without losing volume?

    If price and mix rise without a volume decline, CCEP's pricing power and cost per case improve, supporting margins and cash generation. If volume falls as prices rise, the company may be trading share for revenue, which weakens the distribution scale that underpins the bottler model.

  • Will Asia-Pacific additions earn the same returns as CCEP's European core?

    The Asia-Pacific acquisitions added volume and geographies, but returns depend on distribution density, cooler placement and integration. If those markets earn lower returns than the European core, growth dilutes group return on capital and free cash flow rather than strengthening the business.

  • Are CCEP's largest retail customers gaining bargaining leverage?

    If large grocers and discounters gain leverage, they can demand lower prices or deeper promotions, compressing CCEP's revenue per case and margins. The answer determines whether CCEP's route-to-market scale is enough to protect pricing against concentrated buyers.

02

Financial quality

Financial quality: cash-backed earnings, leveraged returns

Earnings quality: Strong. Operating cash flow covered net income 1.5 to 2.2 times in each of the last five fiscal years, and free cash flow was positive in all five. Gross margin has held between 35.3% and 37.0% since FY2021, so pricing and input costs have moved together. Where the record is less comfortable is the capital structure: ROE of 17.2% in FY2024 and an estimated 23.8% in FY2025 sits on ROA near 5%, and the arithmetic joining them is leverage. Assets run at roughly 3.7 times equity, and liabilities are 71% to 75% of assets in every year shown.

Five years: steady margins, demanding balance sheet
€bn unless notedFY2021FY2022FY2023FY2024FY2025H1 2026Assessment
Revenue13.7617.3218.3020.4420.9010.72Adequate
Gross margin (%)37.035.936.835.635.635.3Adequate
Operating margin (%)11.012.112.810.413.313.6Adequate
Net margin (%)7.18.79.16.99.39.1Adequate
ROE (%)15.020.821.617.223.811.9Strong, leverage-assisted
ROA (%)4.15.25.74.76.43.0Adequate
Liabilities/assets (%)75.274.672.771.172.273.0Weak
Interest cover (x)17.216.615.310.99.69.9Strong
Operating cash flow2.122.932.813.062.950.92Strong
Free cash flow1.672.332.132.272.200.60Exceptional
Operating cash flow/net income (x)2.21.91.72.21.50.9Strong
Implied capex/revenue (%)3.33.53.73.93.63.0Adequate
Goodwill/equity (%)666257555856Weak

*FY2025 and H1 2026 returns calculated on average equity and average total assets; H1 figures cover six months and are not annualized. Capex implied as operating cash flow less free cash flow.

Revenue nearly doubled between FY2021 and FY2025, but the 25.9% jump in FY2022 followed a €5.6bn investing outflow in FY2021, which points to acquired volume. More telling is the operating margin, which fell to 10.4% in FY2024 and recovered to 13.3% in FY2025 while gross margin moved less than half a point. Both the pressure and the recovery sat below the gross profit line, in operating costs, which makes FY2024 look like the outlier and FY2025 closer to trend. The company said in its August 4, 2026 half-year release that efficiencies drove margin expansion in H1 2026 with a further reduction in opex as a share of revenue.

Returns: leverage and buybacks carry the ROE

The gap between a 17–24% ROE and a 5% ROA is the capital structure, not a rounding difference. Liabilities of €21.57bn against €29.87bn of assets at December 31, 2025 leave a thin equity base, and it keeps thinning: equity fell €0.66bn during FY2025 even though net income was €1.94bn, which implies returns of capital well above earnings once currency and other equity movements are counted. Financing outflows of €2.89bn against €2.20bn of free cash flow, with cash falling from €1.56bn to €0.92bn, tell the same story. Diluted EPS rose 9.1% in H1 2026 against 5.8% growth in profit after tax, so roughly three points of that gain came from a smaller share count. Buybacks lift EPS and ROE while leaving ROA untouched, so ROA near 5%, on an asset base carrying €4.54bn of goodwill, is the more honest read.

Growth now depends on volume and mix

H1 2026 revenue rose 4.4% to €10.72bn, days-adjusted volumes grew 2.2%, and revenue per unit case rose just 0.4% to €5.34. Price is barely contributing, and cost of sales per case rose slightly faster at 0.6% to €3.46, leaving gross profit per case roughly flat. The offset is mix and physical reach: zero-sugar volumes up about 10%, sports drinks up 12%, and more than 80,000 coolers placed, a 5% increase in the fleet, which supports single-serve and higher-priced sales. That is a slower growth model than price-led expansion and a more expensive one to run. Cost control becomes the margin lever, and the levers named so far, including a Manila shared-services center that has passed 250 staff, are small against €20.9bn of revenue.

Cash conversion is real, and the calendar helps
€bn unless notedH1 2025H2 2025H1 2026AssessmentTrend
Revenue10.2710.6310.72AdequateFlat
Operating profit1.361.431.46AdequateImproving
Net income0.911.030.97AdequateFlat
Net margin (%)8.99.79.1AdequateFlat
Total assets31.7929.8732.47AdequateFlat
Total liabilities23.2821.5723.71WeakFlat
Total equity8.037.838.28WeakFlat
Net PP&ENot disclosedNot disclosedNot disclosed——
Operating cash flow0.991.930.92StrongSecond-half weighted
Free cash flow0.641.510.60StrongSecond-half weighted
Implied capex0.350.420.32AdequateFlat
Operating cash flow/net income (x)1.11.90.9AdequateSeasonal

H2 2025 flows are FY2025 less H1 2025, with balance-sheet items at December 31, 2025. H1 2026 ended July 3, 2026.

The interim numbers explain part of the annual conversion record. Operating cash flow was 0.9 times net income in H1 2026 and 1.9 times in H2 2025, because working capital unwinds in the second half. The annual 1.5–2.2 times is genuine, but it is not evidence that every euro of profit arrives when earned. Depreciation and amortization of about €0.63bn a year widens the gap between earnings and cash further. Capex looks modest for a bottler, implied at €0.75bn, or 3.6% of revenue and about 1.2 times depreciation, while management describes record investment, so a meaningful part of that spending may sit in operating costs, leases or intangibles instead of the fixed-asset line. The free cash flow record is partly a function of how little is spent on owned assets.

What to watch: payouts, liquidity, goodwill, unit costs
  • Funding of distributions. FY2025 financing outflows of €2.89bn exceeded free cash flow of €2.20bn and cash fell to €0.92bn, the lowest of the five years shown. A second year of that pattern would mean the payout leans on new borrowing.
  • Liquidity and debt mix. Current liabilities were €9.36bn at the 2026 half-year, and no current-asset figure is published for FY2025 or H1 2026, so the current ratio cannot be refreshed from the last balance sheet; it was 0.81 at FY2024. Short-term debt fell from €1.39bn to €0.47bn between FY2024 and FY2025 with long-term debt not broken out for FY2025, so the maturity mix may have shifted even if the total did not.
  • Goodwill. €4.54bn against €7.83bn of equity is 58%. It has moved only with currency since FY2022, and an impairment would land on an already thin equity base.
  • Unit costs against unit prices. Cost per case grew 0.6% while revenue per case grew 0.4% in H1 2026. The gap is small; sustained into the second half, it would test the FY2025 margin recovery.

Questions worth following

  • Will CCEP's dividends and buybacks stay inside free cash flow?

    FY2025 financing outflows of €2.89 billion exceeded €2.20 billion of free cash flow and cash fell to €0.92 billion. Whether payouts stay covered decides if shareholder returns keep compounding or start adding leverage to a balance sheet that already carries €21.6 billion of liabilities.

  • Can CCEP lift revenue per unit case without losing volume?

    If price and mix rise without a volume decline, CCEP's pricing power and cost per case improve, supporting margins and cash generation. If volume falls as prices rise, the company may be trading share for revenue, which weakens the distribution scale that underpins the bottler model.

  • Will faster unit-cost inflation squeeze CCEP's gross margin?

    Cost of sales per unit case rose 0.6% in H1 2026 while revenue per case rose 0.4%, inverting the relationship that held gross margin near 36% for five years. A persistent gap would erode the FY2025 operating margin recovery and the profit-per-case base behind it.

Generated by DeepVal AI. Data and models may contain errors or be outdated. For research only; not personalized investment advice.

Go beyond the preview

Continue reading the full report

  1. Key risksWhat could break the investment case
  2. Valuation and margin of safetyWhat the current price assumes, and how much room for error it leaves
  3. SummaryOur overall judgement and what to watch next

Free to sign up · 20 research points · unlocking this report uses 10

20 points cover 2 full reports. No card needed.

Research reflects its generation date. Preview the first two modules.

More on Coca-Cola European Partners PLC